Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®
Clinical trial NCT02499900 · COMPLETED
Trial details
- NCT number
- NCT02499900
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-10
- Primary completion
- 2017-01-10
- Enrollment
- 861
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.